Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+101.0%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+101.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025142.98%
202469.77%
20231.61%
202217.61%
2021-10.16%
2020-4.52%
2019-24.70%
2018-95.10%
2017-49.59%
2016-39.00%